Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.
about
Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join ForcesSphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel DiseaseDistinct roles for hematopoietic and extra-hematopoietic sphingosine kinase-1 in inflammatory bowel disease.Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune system.A novel pathway by which the environmental toxin 4-Nonylphenol may promote an inflammatory response in inflammatory bowel disease.Sphingolipids in mitochondria.Novel sphingosine kinase-1 inhibitor, LCL351, reduces immune responses in murine DSS-induced colitis.Ceramidases, roles in sphingolipid metabolism and in health and disease.Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.Ceramide synthase 2 deficiency aggravates AOM-DSS-induced colitis in mice: role of colon barrier integrity.A neutral ceramidase, NlnCDase, is involved in the stress responses of brown planthopper, Nilaparvata lugens (Stål).AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.Alkaline ceramidase 2 is essential for the homeostasis of plasma sphingoid bases and their phosphates.Gut Sphingolipid Composition as a Prelude to Necrotizing Enterocolitis
P2860
Q26765948-65E7EDC0-A6A8-4499-A277-22A789810ED9Q28073700-66336961-C494-4A34-9D86-C4CB31AA4AA2Q34612187-AD1ED413-0422-4FD2-83E6-B5973A496B63Q36774954-342041BE-0E7B-49E9-988D-7DA973597A4FQ37719290-24EEB735-A3B1-4CEE-8CE1-6E84A0C037EAQ38809404-A37A4F53-BA3F-430C-87C3-54D543FDDB28Q38854721-1B5EE891-B632-4E66-AB72-DCFCCA98953FQ38988326-D59E047D-82F7-4859-BAC6-CBEEE9C12B27Q39014759-6EEF4765-4604-48DF-A6F2-D613CCEF1E95Q43895216-29F84037-DCAF-405F-8966-937EB6AA5473Q47551588-688334E2-7C11-4DC6-BA0D-A4AA2E876EA8Q52319633-60ED890D-8316-48B0-8583-6DE372ED551AQ52699532-D75BDD62-681F-4A56-BE3A-D8B69D6D144CQ57281486-491C0ACB-723F-4D46-9A00-84E8B86F4C6E
P2860
Loss of neutral ceramidase increases inflammation in a mouse model of inflammatory bowel disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Loss of neutral ceramidase inc ...... of inflammatory bowel disease.
@en
type
label
Loss of neutral ceramidase inc ...... of inflammatory bowel disease.
@en
prefLabel
Loss of neutral ceramidase inc ...... of inflammatory bowel disease.
@en
P2093
P2860
P1476
Loss of neutral ceramidase inc ...... of inflammatory bowel disease.
@en
P2093
Ashley J Snider
Jonathan A Sticca
Lina M Obeid
Russell W Jenkins
Toshihiko Kawamori
P2860
P304
P356
10.1016/J.PROSTAGLANDINS.2012.08.003
P577
2012-08-31T00:00:00Z